Since ILC2 can express PD‐123, 25 and with current anti‐PD‐1 or anti‐PD‐L1 therapies for the treatment of cancers,14 it would be interesting to examine whether some of the functions associated with ILC2 are also affected in these patients. The gene discussed is PDCD1; the disease is cancer.